Vai al contenuto principale della pagina
Titolo: |
Novel Technologies for Vaccine Development / / edited by Igor S Lukashevich, Haval Shirwan
![]() |
Pubblicazione: | Vienna : , : Springer Vienna : , : Imprint : Springer, , 2014 |
Edizione: | 1st ed. 2014. |
Descrizione fisica: | 1 online resource (393 p.) |
Disciplina: | 610 |
615.19 | |
615372 | |
616079 | |
Soggetto topico: | Vaccines |
Pharmaceutical technology | |
Immunology | |
Vaccine | |
Pharmaceutical Sciences/Technology | |
Persona (resp. second.): | LukashevichIgor S |
ShirwanHaval | |
Note generali: | Description based upon print version of record. |
Nota di bibliografia: | Includes bibliographical references at the end of each chapters. |
Nota di contenuto: | Reverse Genetics Approaches for Rational Design of Inactivated and Live-Attenuated Influenza Vaccines -- Viral-Vectored Vaccines to Control Pathogenic Filoviruses -- Alphavirus Replicon Vectors for Prophylactic Applications and Cancer Intervention -- Current Status and Future of Polio Vaccines and Vaccination -- Current Status of Hantavirus Vaccines Development -- Experimental DNA-Launched Live Attenuated Vaccines against Infections Caused by Flavi- and Alphaviruses -- Sugar-Based Immune Adjuvants for Use in Recombinant, Viral, Vector, DNA and Other Styles of Vaccines -- Adenovirus-based Vectors for the Development of Prophylactic and Therapeutic Vaccines -- Radiovirotherapy for the Treatment of Cancer -- TRICOM Poxviral-Based Vaccines for the Treatment of Cancer -- The Use of Oncolytic Herpesvirus for the Treatment of Cancer -- SA-4-1BBL; A Novel form of the 4-1BB Costimulatory Ligand as an Adjuvant Platform for the Development of Subunit Cancer Vaccines. |
Sommario/riassunto: | This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new generation of vector-based vaccines. Furthermore, specific topics such as delivery and adjuvant and protection strategies for cell-mediated-based vaccines are presented. Given its scope, the book is a “must read” for all those involved in vaccine development, both in academia and industrial vaccine development. |
Titolo autorizzato: | Novel Technologies for Vaccine Development ![]() |
ISBN: | 3-7091-1818-2 |
Formato: | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione: | Inglese |
Record Nr.: | 9910298336303321 |
Lo trovi qui: | Univ. Federico II |
Opac: | Controlla la disponibilità qui |